# The Practical Evidence of Antidiabetic Combination Therapy in Korea

> **NCT02231021** · PHASE4 · COMPLETED · sponsor: **Kun-Ho Yoon** · enrollment: 216 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** alogliptin
- **DRUG:** Pioglitazone
- **DRUG:** alogliptin + pioglitazone

## Key facts

- **NCT ID:** NCT02231021
- **Lead sponsor:** Kun-Ho Yoon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2018-10-22
- **Final completion:** 2019-01-28
- **Target enrollment:** 216 (ACTUAL)
- **Last updated:** 2019-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231021, "The Practical Evidence of Antidiabetic Combination Therapy in Korea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02231021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*